Bms-907351

Intracerebral Hemorrhage

Karolinska InstitutetN/AActive

D

30/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 15/ 100
Competitive Position: 81/ 100

Competitive context

23 Active assets in the Intracerebral Hemorrhage cohort.

Asset / Sponsor	Phase	Rating
NEPENTHE Henry M. Jackson Foundation for the Advancement of Military Medicine	Phase 4	BB
Rivaroxaban Imperial College London	Phase 3	B
Dabigatran Imperial College London	Phase 3	B
Apixaban Region Stockholm	Phase 3	B
PROPRANOLOL Tang-Du Hospital	Phase 2/3	B

View all 42 →

Same molecule, other indications

Bms-907351 is also rated in:

renal carcinomaDormant

BB

Indicative ·

70 / 100

castration-resistant prostate carcinomaDormant

BB

Indicative ·

70 / 100

non-small cell lung carcinomaDormant

BB

Indicative ·

68 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.